Radiation enhancement by 9-aminocamptothecin: the effect of fractionation and timing of administration

This publication has 11 references indexed in Scilit:

• The Current Status of Irinotecan (CPT‐11) in the United States
  Annals of the New York Academy of Sciences, 1996
• Schedule‐dependent Efficacy of Camptothecins in Models of Human Cancer^a
  Annals of the New York Academy of Sciences, 1996
• Radiation lethality enhancement with 9-aminocamptothecin: Comparison to other topoisomerase I inhibitors
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy
  Cancer, 1996
• Preoperative infusional chemoradiation and surgery with or without and electron beam intraoperative boost for advanced primary rectal cancer
  International Journal of Radiation Oncology*Biology*Physics, 1995
• DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.
  Molecular and Cellular Biology, 1994
• DNA topoisomerase I and II in cancer chemotherapy: update and perspectives
  Cancer Chemotherapy and Pharmacology, 1993
• Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation
  Cell Proliferation, 1992
• DNA Damaging and Cell Cycle Effects of the Topoisomerase I Poison Camptothecin in Irradiated Human Cells
  International Journal of Radiation Biology, 1992